Literature DB >> 19341942

New tools in nail disorders.

Bertrand Richert1, Nadine Lateur, Anne Theunis, Josette Andre.   

Abstract

Tumors of the nail unit may be difficult to diagnose because of the screening effect of the nail plate. In longitudinal melanonychia, several new promising techniques assist with early diagnosis of melanoma (in vivo matrix dermoscopy and immunohistochemistry) as well as sparing as much of the healthy tissues as is possible (shave biopsy technique). Diagnosing nail disorders is in some instances difficult both for the clinician and the pathologist. New tools such as polymerase chain reaction have been proposed for onychomycosis, which accounts for more than half of nail conditions, will allow quick and accurate diagnosis. However, polymerase chain reaction analysis remains expensive and is not routinely used by clinicians. Scoring nail dystrophy by clinical observation remains very subjective; therefore, severity indexes have been proposed. Another emerging noninvasive technique is forensic analysis of nail clippings for detection of drug intake and abuse, as well as exposure to environmental pollution.

Entities:  

Mesh:

Year:  2009        PMID: 19341942     DOI: 10.1016/j.sder.2008.12.007

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

1.  [Operative therapy of acral melanomas].

Authors:  M Möhrle; V Lichte; H Breuninger
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

2.  Dermoscopic patterns in patients with a clinical diagnosis of onychomycosis-results of a prospective study including data of potassium hydroxide (KOH) and culture examination.

Authors:  Miriam América Jesús-Silva; Ramón Fernández-Martínez; Rodrigo Roldán-Marín; Roberto Arenas
Journal:  Dermatol Pract Concept       Date:  2015-04-30

3.  Onychoscopy: an observational study in 237 patients from the Kashmir Valley of North India.

Authors:  Yasmeen J Bhat; Muzafar A Mir; Abid Keen; Iffat Hassan
Journal:  Dermatol Pract Concept       Date:  2018-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.